Physician profile
Xin Yang
NPI 1528034154
$3,190.55
in general payments reported to CMS, 2019-2025
27 companies · $36.36 in 2025
The $36.36 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $250 · 2021: $146 · 2022: $173 · 2023: $474 · 2024: $864 · 2025: $36.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $616.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $359.95 | 2019-2024 | |
| Medtronic, INC. | $222.52 | 2021-2025 | Symplicity G3, Onyx Frontier, Telescope |
| Abiomed | $205.71 | 2019-2024 | Impella |
| Shockwave Medical, INC | $205.66 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.74 | 2019-2025 | Lifevest |
| Pfizer INC. | $161.02 | 2019 | |
| Boston Scientific Corporation | $146.54 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Abbott Laboratories | $143.65 | 2020-2024 | Assurity |
| Amgen INC. | $141.84 | 2019 | |
| Inari Medical, INC. | $133.65 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lantheus Medical Imaging, INC. | $122.84 | 2023-2024 | Definity |
| Edwards Lifesciences Corporation | $86.27 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $76.73 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.38 | 2019-2024 | Jardiance |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $70.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $36.14 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $27.91 | 2023 | Arcalyst |
| Atricure, INC. | $26.55 | 2021 | |
| Astellas Pharma US INC | $24.11 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $24.08 | 2021-2022 | |
| Terumo Medical Corporation | $22.67 | 2023 | Azur Cx Detachable |
| Angiodynamics, INC. | $22.07 | 2022 | |
| Medline Industries Lp | $21.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.72 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.00 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xin Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.